ClinConnect ClinConnect Logo
Search / Trial NCT06400147

Strategy Training for Individuals With Unilateral Neglect

Launched by UNIVERSITY OF PITTSBURGH · May 1, 2024

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new training program designed to help people who have had a stroke and experience a condition called unilateral neglect. This condition makes it hard for individuals to pay attention to one side of their body or their surroundings, which can make daily activities challenging. The goal of the study is to see if a type of training called metacognitive strategy training can improve awareness and reduce difficulties caused by neglect.

To participate in this trial, individuals must be at least 18 years old, have had a stroke, and be currently receiving care in a rehabilitation facility. They also need to show signs of neglect based on specific tests. Unfortunately, those with severe language difficulties, dementia, or certain mental health conditions are not eligible. Participants can expect to engage in activities that aim to enhance their awareness and help them manage their daily tasks better. The study is currently recruiting, so there are opportunities for eligible individuals to join and potentially benefit from this innovative approach.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • primary diagnosis of stroke
  • admission to inpatient rehabilitation facility
  • ≥18 years old
  • presence of neglect as determined by score of \<18 on the Virtual Reality Lateralized Attention Test (VRLAT) or score below established cutoff for neglect on one of the six subtests of the Behavioral Inattention Test (BIT)
  • Exclusion Criteria:
  • Boston Diagnostic Aphasia Examination (BDAE) Severity Scale score of 0 (severe global aphasia)
  • diagnosis of dementia indicated in medical record
  • diagnosis of active major depressive disorder/bipolar/psychotic disorder indicated in medical record
  • anticipated length of stay \<10 days

About University Of Pittsburgh

The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.

Locations

Pittsburgh, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Emily Grattan, PhD

Principal Investigator

University of Pittsburgh

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported